மினசோட்டா பலகை ஆஃப் மருந்தகம் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Hundreds of Minnesotans with diabetes received life-saving medication at low cost in the first six months of the state's new emergency insulin law, according to a new report from the Minnesota Board of Pharmacy. The backdrop: The Alec Smith Insulin Affordability Act, which passed with bipartisan support last year, ensures access to a 30-day supply of insulin for a $35 co-pay. The cost of the long-term program is $50 every three months.Get market news worthy of your time with Axios Markets. Subscribe for free.The goal of the bill, named after a 26-year-old who died after rationing his medicine, was to save people from risking their health over cost concerns. By the numbers: More than 200 residents were able to access the 30-day supply.Hundreds more enrolled in a program requiring manufacturers to provide insulin to low-income residents at reduced price for up to a year.The bill, which the pharmaceutical industry is challenging in court, cost manufacturers more than $2 million betwe ....

Minnesota Board Of Pharmacy , Axios Markets , Bipartisan Support , மினசோட்டா பலகை ஆஃப் மருந்தகம் , அச்சுக்கள் சந்தைகள் ,